Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan W Barnett

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Current HIV Research|November 30, 2007
Broadening our view of protective antibody responses against HIVBrian Burke, Susan W Barnett
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Journal of Virology|January 29, 2003
Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable regionIndresh K Srivastava, Keating VanDorsten, Lucia Vojtech, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Virology|July 20, 2002
Species tropism of chimeric SHIV clones containing HIV-1 subtype-A and subtype-E envelope genesSunee Himathongkham, Gordon C Douglas, Adrienne Fang, et al.
Vaccine|January 5, 2005
Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequencesThomas J Scriba, Jan zur Megede, Richard H Glashoff, et al.
Vaccines|May 18, 2016
Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African RegionsZihao Wang, Clarisse Lorin, Marguerite Koutsoukos, et al.
Virology|March 3, 2009
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbitsBrian Burke, Victor Raúl Gómez-Román, Ying Lian, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current HIV Research|November 30, 2007
Broadening our view of protective antibody responses against HIVBrian Burke, Susan W Barnett
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Journal of Virology|January 29, 2003
Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable regionIndresh K Srivastava, Keating VanDorsten, Lucia Vojtech, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Virology|July 20, 2002
Species tropism of chimeric SHIV clones containing HIV-1 subtype-A and subtype-E envelope genesSunee Himathongkham, Gordon C Douglas, Adrienne Fang, et al.
Vaccine|January 5, 2005
Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequencesThomas J Scriba, Jan zur Megede, Richard H Glashoff, et al.
Vaccines|May 18, 2016
Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African RegionsZihao Wang, Clarisse Lorin, Marguerite Koutsoukos, et al.
Virology|March 3, 2009
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbitsBrian Burke, Victor Raúl Gómez-Román, Ying Lian, et al.
Pageof 10